PCM
BLFS icon

Penn Capital Management’s BioLife Solutions BLFS Stock Holding History

Penn Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-322,873
Closed -$3.07M – 198
2020
Q1 		$3.07M Buy
+322,873
New +$4.43M 0.51% 74

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SPA
Sentinel Pension Advisors Wakefield, Massachusetts $676M AUM 15.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Penn Capital Management's BLFS Position: Q2 2020 in Review

Penn Capital Management sold out of BioLife Solutions (BLFS) in Q2 2020, closing a stake of 322,873 shares — an estimated $3.07M sold.

Penn Capital Management first reported a position in BLFS in Q1 2020 and held it in 1 quarter. The position peaked at $3.07M in Q1 2020. 82 funds tracked by Wall St. Rank hold BLFS as of Q2 2020.

  • Penn Capital Management reported no remaining BioLife Solutions position as of Q2 2020 after selling out during the quarter.
  • Penn Capital Management sold 322,873 BioLife Solutions shares in Q2 2020, an estimated $3.07M.
  • Penn Capital Management first reported a position in BioLife Solutions in Q1 2020 and held it in 1 quarter.
  • Penn Capital Management's BioLife Solutions position peaked at $3.07M in Q1 2020.
  • 82 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2020.

Based on Penn Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.